Patents by Inventor Konrad Traugott Beyreuther

Konrad Traugott Beyreuther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040265847
    Abstract: The present invention is directed to methods for treating Alzheimer's Disease by modulating divalent cation, trivalent cation and/or heparin interaction with amyloid precursor protein (APP). In particular, the present invention is directed to methods for treating Alzheimer's Disease by administering to a patient with Alzheimer's Disease a therapeutically effective amount of a zinc binding agent for modulating the interaction of zinc and/or heparin with APP and thereby preventing the aberrant processing of APP.
    Type: Application
    Filed: November 19, 2003
    Publication date: December 30, 2004
    Inventors: Colin Louis Masters, Ashley Ian Bush, Konrad Traugott Beyreuther
  • Patent number: 5705401
    Abstract: The present invention relates to a method of assaying for Alzheimer's disease in a human by determining the relative abundance of one or more forms of amyloid precursor protein (APP) or the enzyme responsible for said forms in circulatory fluid and to a method for treating the disease by modulating divalent cation, trivalent cation and/or heparin interaction with APP.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: January 6, 1998
    Assignee: The University of Melbourne
    Inventors: Colin Louis Masters, Ashley Ian Bush, Konrad Traugott Beyreuther